dactinomycin has been researched along with Disease Exacerbation in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (11.54) | 18.2507 |
| 2000's | 10 (38.46) | 29.6817 |
| 2010's | 12 (46.15) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Acha, T; Bergeron, C; Brisse, H; Coulomb-L'Hermine, A; de Camargo, B; Furtwängler, R; Godzinski, J; Graf, N; Howell, L; Melchior, P; Pasqualini, C; Pritchard-Jones, K; Smets, AM; Teixeira, RAP; van den Heuvel-Eibrink, MM; van Tinteren, H; Verschuur, AC; Vujanic, G | 1 |
| Gao, P; Liu, HT; Liu, L; Liu, S; Ma, RR | 1 |
| Chi, YY; Daw, NC; Dome, JS; Ehrlich, PF; Fernandez, CV; Geller, JI; Grundy, PE; Kalapurakal, JA; Khanna, G; Kim, Y; Mullen, EA; Perlman, EJ; Tian, J; Warwick, AB | 1 |
| Ariyan, C; Brady, MS; Rafferty, B; Steinman, J | 1 |
| Amann, G; Furtwängler, R; Gräber, S; Graf, N; Kager, L; Leuschner, I; Niggli, F; Schenk, JP; Schmolze, M; von Schweinitz, D | 1 |
| Graf, N; Pritchard-Jones, K; van den Heuvel-Eibrink, MM; van Tinteren, H | 1 |
| Cloos, J; de Graaf, P; de Jong, MC; Dorsman, JC; Kaspers, GL; Kooi, IE; Meijers-Heijboer, H; Mol, BM; Moll, AC; Schouten-van Meeteren, AY; Te Riele, H; van der Valk, P; van Mil, SE | 1 |
| Bashir, MR; Beasley, GM; Bhatti, L; Brys, AK; Jaffe, TA; Mosca, PJ; Nath, NS; Salama, AK; Tyler, DS | 1 |
| Anderson, JR; Arndt, CA; Donaldson, SS; Hawkins, DS; Lyden, ER; Morris, CD; Rodeberg, DA; Wolden, SL | 1 |
| Kam, PC; Kroon, HM; Lin, DY; Thompson, JF | 1 |
| Correa, H; Crane, G; Friedman, DL; Lovvorn, HN; Rauth, TP; Slone, J | 1 |
| Cyriac, S; Rajendranath, R; Sagar, TG; Sridevi, V | 1 |
| Raveesunthornkiet, M; Ruangtrakool, R; Sanpaki, K; Thorner, PS; Treetipsatit, J | 1 |
| Brandt, JD; Kiuchi, Y; Mochizuki, H; Murphy, CJ; Russell, P | 1 |
| Boullier, S; Février, M; Garcia, S; Gougeon, ML; Lecoeur, H; Ledru, E | 1 |
| Hosoi, H; Iehara, T; Misawa, A; Sawada, T; Sugimoto, T; Tsuchiya, K | 1 |
| Dickman, PS; Donaldson, SS; Fryer, CJ; Gebhardt, MC; Grier, HE; Krailo, MD; Link, MP; Meyers, PA; Miser, JS; Moore, S; Perlman, EJ; Pritchard, DJ; Rausen, AR; Tarbell, NJ; Vietti, TJ | 1 |
| Bysani, S; Chandrasekar, B; Mummidi, S | 1 |
| Bisogno, G; Casale, F; Cecchetto, G; De Salvo, G; Di Martino, M; Di Tullio, MT; Donfrancesco, A; Donofrio, V; Ferrari, A; Indolfi, P; Martone, A | 1 |
| Bernstein, M; Chen, Z; Donaldson, SS; Fryer, CJ; Gebhardt, MC; Grier, HE; Krailo, M; Laurie, F; Miser, JS; Tarbell, NJ; Yock, TI | 1 |
| Goldwein, J; Lange, B; Molloy, PT; Moshang, T; Packer, RJ; Phillips, PL; Rorke, LB; Sernyak, H; Sutton, LN | 1 |
| Bekradda, M; Culine, S; Droz, JP; Farhat, F; Terrier-Lacombe, MJ; Theodore, C | 1 |
| Eide, EJ; Green, WF; Hicks, GG; Hsieh, FF; Kelley, LL; Miller, MD; Prasher, JM; Ruley, HE | 1 |
| Anderson, JR; Baker, KS; Breneman, JC; Crist, WM; Grier, HE; Link, MP; Maurer, HM; Qualman, SJ; Wiener, ES | 1 |
| Gotoh, A; Keller, ET; Matsumoto, T; Mizokami, A; Yamada, H | 1 |
| Crooke, MJ; Delahunt, B; Lewis, ME; Pringle, KC; Wiltshire, EJ | 1 |
6 trial(s) available for dactinomycin and Disease Exacerbation
| Article | Year |
|---|---|
Outcome of patients with stage IV high-risk Wilms tumour treated according to the SIOP2001 protocol: A report of the SIOP Renal Tumour Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dactinomycin; Disease Progression; Disease-Free Survival; Female; Humans; Infant; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Survival Rate; Time Factors; Vincristine; Wilms Tumor | 2020 |
Factors associated with response, survival, and limb salvage in patients undergoing isolated limb infusion.
Topics: Adult; Aged; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Merkel Cell; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Disease Progression; Drug Administration Schedule; Extremities; Female; Humans; Kaplan-Meier Estimate; Limb Salvage; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Staging; Prospective Studies; Retrospective Studies; Sarcoma; Skin Neoplasms; Treatment Outcome; Tumor Burden | 2014 |
Local Control for Intermediate-Risk Rhabdomyosarcoma: Results From D9803 According to Histology, Group, Site, and Size: A Report From the Children's Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease Progression; Disease-Free Survival; Female; Humans; Infant; Lymph Nodes; Male; Meningeal Neoplasms; Radiotherapy Dosage; Retroperitoneal Neoplasms; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Topotecan; Treatment Failure; Tumor Burden; Vincristine | 2015 |
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Neuroectodermal Tumors, Primitive; Prognosis; Sarcoma; Sarcoma, Ewing; Survival Rate; Treatment Failure; Vincristine | 2003 |
Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Confounding Factors, Epidemiologic; Cyclophosphamide; Dactinomycin; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Pelvic Bones; Radiotherapy, Adjuvant; Sarcoma, Ewing; Treatment Outcome; Vincristine | 2006 |
Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease Progression; Disease-Free Survival; Etoposide; Female; Head and Neck Neoplasms; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Neoplasm Staging; Prognosis; Retrospective Studies; Rhabdomyosarcoma, Embryonal; Risk Factors; Vincristine | 2000 |
20 other study(ies) available for dactinomycin and Disease Exacerbation
| Article | Year |
|---|---|
EGR1-Mediated Transcription of lncRNA-HNF1A-AS1 Promotes Cell-Cycle Progression in Gastric Cancer.
Topics: Animals; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin E; Cyclin-Dependent Kinase 4; Cycloheximide; Dactinomycin; Disease Progression; Early Growth Response Protein 1; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; MicroRNAs; Neoplasm Invasiveness; Neoplasm Transplantation; Oncogene Proteins; Promoter Regions, Genetic; RNA, Antisense; RNA, Long Noncoding; RNA, Small Interfering; Stomach Neoplasms; Ubiquitin-Conjugating Enzymes | 2018 |
Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Child, Preschool; Dactinomycin; Disease Progression; Doxorubicin; Female; Humans; Infant; Kidney Neoplasms; Male; Neoplasm Staging; Nephrectomy; Progression-Free Survival; Radiotherapy, Adjuvant; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; United States; Vincristine; Wilms Tumor | 2019 |
Pretreatment for bilateral nephroblastomatosis is an independent risk factor for progressive disease in patients with stage V nephroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease Progression; Doxorubicin; Female; Humans; Infant; Infant, Newborn; Kidney; Kidney Neoplasms; Male; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Nephrectomy; Survival Rate; Tumor Burden; Vincristine; Wilms Tumor | 2014 |
Response to letter commenting on "Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG)".
Topics: Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Disease Progression; Humans; Kidney Neoplasms; Neoplasm Staging; Prognosis; Vincristine; Wilms Tumor | 2015 |
Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression.
Topics: Child, Preschool; Cluster Analysis; Dactinomycin; Disease Progression; DNA Copy Number Variations; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Ontology; Genome, Human; Humans; Infant; Karyotyping; Male; Photoreceptor Cells, Vertebrate; Reproducibility of Results; Retinoblastoma; RNA, Messenger | 2015 |
Computed Tomography-Based Limb Volume Measurements for Isolated Limb Infusion in Melanoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Disease Progression; Feasibility Studies; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lower Extremity; Melanoma; Melphalan; Neoplasm Staging; Prognosis; Retrospective Studies; Skin Neoplasms; Tomography, X-Ray Computed | 2016 |
Efficacy of repeat isolated limb infusion with melphalan and actinomycin D for recurrent melanoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Disease Progression; Female; Humans; Leg; Male; Melanoma; Melphalan; Middle Aged; Recurrence; Skin Neoplasms; Survival Analysis; Time Factors; Treatment Outcome | 2009 |
Laparoscopic nephron-sparing resection of synchronous Wilms tumors in a case of hyperplastic perilobar nephroblastomatosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dactinomycin; Disease Progression; Doxorubicin; Female; Follow-Up Studies; Humans; Hyperplasia; Infant; Kidney Diseases; Kidney Neoplasms; Laparoscopy; Magnetic Resonance Imaging; Neoplasms, Multiple Primary; Nephrons; Precancerous Conditions; Vincristine; Wilms Tumor | 2011 |
Etoposide, cisplatin-etoposide, methotrexate, actinomycin-D as primary treatment for management of very-high-risk gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dactinomycin; Disease Progression; Etoposide; Female; Gestational Trophoblastic Disease; Humans; India; Liver Neoplasms; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Risk; Salvage Therapy; Survival Rate; Treatment Outcome; Young Adult | 2011 |
Teratoid Wilms' tumor: case report of a rare variant that can mimic aggressive biology during chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dactinomycin; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Ifosfamide; Infant; Kidney Neoplasms; Male; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Nephrectomy; Prognosis; Stromal Cells; Vincristine; Wilms Tumor | 2011 |
Altered stability of mRNAs associated with glaucoma progression in human trabecular meshwork cells following oxidative stress.
Topics: Adolescent; Adult; Aged; Blotting, Western; Cells, Cultured; Cytoskeletal Proteins; Dactinomycin; Disease Progression; ELAV Proteins; Eye Proteins; Fluorescent Antibody Technique, Indirect; Glaucoma; Glycoproteins; Humans; Hydrogen Peroxide; Immunohistochemistry; Interleukin-6; Interleukin-8; Matrix Metalloproteinase 3; Matrix Metalloproteinase 9; Microscopy, Confocal; Middle Aged; Osteonectin; Oxidative Stress; Real-Time Polymerase Chain Reaction; RNA, Messenger; Trabecular Meshwork; Young Adult | 2012 |
A nonsecreted variant of interleukin-4 is associated with apoptosis: implication for the T helper-2 polarization in HIV infection.
Topics: Alternative Splicing; Antibodies, Monoclonal; Antibody Specificity; Apoptosis; Cells, Cultured; Culture Media; Dactinomycin; Disease Progression; HIV Infections; Humans; Interleukin-4; Microscopy, Confocal; Protein Isoforms; Th1 Cells; Th2 Cells | 2003 |
Regression of refractory rhabdomyosarcoma after allogeneic stem-cell transplantation.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Female; Graft vs Tumor Effect; Head and Neck Neoplasms; Humans; Ifosfamide; Immunosuppressive Agents; Neoplasm Recurrence, Local; Nimustine; Peripheral Blood Stem Cell Transplantation; Rhabdomyosarcoma; Transplantation Conditioning; Vincristine | 2003 |
CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation.
Topics: Aorta; Arteriosclerosis; Cell Adhesion; Cell Death; Cell Division; Cell Separation; Cells, Cultured; Chemokine CXCL16; Chemokines, CXC; Dactinomycin; Disease Progression; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Flow Cytometry; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; I-kappa B Kinase; Macrophages; Membrane Proteins; Myocytes, Smooth Muscle; NF-kappa B; Nucleic Acid Synthesis Inhibitors; Pertussis Toxin; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, Immunologic; Receptors, Scavenger; Signal Transduction; Time Factors | 2004 |
Prognostic factors in pleuro-pulmonary blastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasm Staging; Pleural Neoplasms; Pneumonectomy; Prognosis; Pulmonary Blastoma; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Second-Look Surgery; Treatment Outcome; Vincristine | 2007 |
Long-term outcome of hypothalamic/chiasmatic astrocytomas in children treated with conservative surgery.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Biopsy; Chemotherapy, Adjuvant; Child; Child Development; Child, Preschool; Cranial Nerve Neoplasms; Dactinomycin; Disease Progression; Feasibility Studies; Follow-Up Studies; Humans; Hypothalamic Neoplasms; Magnetic Resonance Imaging; Optic Chiasm; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Thyroid Hormones; Tomography, X-Ray Computed; Treatment Outcome; Vincristine; Visual Acuity | 1995 |
Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Dactinomycin; Disease Progression; Etoposide; Follow-Up Studies; Germinoma; Humans; Lymph Node Excision; Male; Middle Aged; Neoplasm Staging; Retroperitoneal Space; Retrospective Studies; Testicular Neoplasms; Treatment Outcome; Vinblastine | 1996 |
Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cell Differentiation; Cell Division; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Dactinomycin; Disease Progression; DNA Damage; Erythroblasts; Erythropoietin; Female; Friend murine leukemia virus; G1 Phase; Gene Expression; Genes, p53; Leukemia, Erythroblastic, Acute; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mutation; Transcriptional Activation; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1998 |
Tumor necrosis factor-alpha represses androgen sensitivity in the LNCaP prostate cancer cell line.
Topics: Antibiotics, Antineoplastic; Blotting, Northern; Blotting, Western; Carcinogens; Cell Division; Dactinomycin; Dihydrotestosterone; Disease Progression; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Luciferases; Male; Promoter Regions, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; RNA Processing, Post-Transcriptional; RNA, Messenger; RNA, Neoplasm; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2000 |
Serum creatine kinase levels parallel the clinical course for rhabdomyomatous Wilms tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Creatine Kinase; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Infant; Kidney Neoplasms; Mesna; Neoplasm Recurrence, Local; Nephrectomy; Reference Standards; Rhabdomyoma; Vincristine; Wilms Tumor | 2001 |